Intra-Articular Administration of Recombinant Human Proteoglycan 4 (rhPRG4) as a Potential Therapy for Temporomandibular Joint Osteoarthritis: A Preclinical Histopathological Study. [PDF]
Iturriaga V +5 more
europepmc +1 more source
ZC3H13 Promotes NSUN4-Mediated Chondrocyte Mitochondrial Dysfunction and Pyroptosis in Temporomandibular Joint Osteoarthritis. [PDF]
Chen Y, Ren H.
europepmc +1 more source
Redefining Clinical Trials on Regenerative Therapies to Target Responsiveness in Temporomandibular Joint Osteoarthritis Treatment. [PDF]
Tesch RS +4 more
europepmc +1 more source
Novel insights into the role of ferroptosis in temporomandibular joint osteoarthritis and knee osteoarthritis. [PDF]
Zhang Y +7 more
europepmc +1 more source
Targeted soluble epoxide hydrolase inhibits M1 macrophage polarization to improve cartilage injury in temporomandibular joint osteoarthritis. [PDF]
Yan B +6 more
europepmc +1 more source
Platelet-rich plasma alleviates endoplasmic reticulum stress via the IGF1R-PI3K-AKT pathway in temporomandibular joint osteoarthritis: an in vivo clinical trial. [PDF]
Liu S, Sun L, Fu J, Cai B, Hao Y.
europepmc +1 more source
Dual-functional ROS-responsive hydrogel alleviates temporomandibular joint osteoarthritis by enhancing cartilage repair and mitigating inflammation. [PDF]
Kuang Y +5 more
europepmc +1 more source
Akt2 inhibition alleviates temporomandibular joint osteoarthritis by preventing subchondral bone loss. [PDF]
Feng SY +5 more
europepmc +1 more source

